JFG
RCKT icon

Jefferies Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Jefferies Financial Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$15K – 1962
2023
Q4 		$15K Sell
500
-4,400
-90% -$97.1K ﹤0.01% 1620
2023
Q3 		$100K Buy
+4,900
New +$89.1K ﹤0.01% 1458

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Financial Group's RCKT Position: Q1 2025 in Review

Jefferies Financial Group sold out of Rocket Pharmaceuticals (RCKT) in Q1 2025, closing a stake of 10,000 shares — an estimated $126K sold.

Jefferies Financial Group first reported a position in RCKT in Q1 2023 and held it in 5 quarters. The position peaked at $4.03M in Q1 2023. 236 funds tracked by Wall St. Rank hold RCKT as of Q1 2025.

  • Jefferies Financial Group reported no remaining Rocket Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 10,000 Rocket Pharmaceuticals shares in Q1 2025, an estimated $126K.
  • Jefferies Financial Group first reported a position in Rocket Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Rocket Pharmaceuticals position peaked at $4.03M in Q1 2023.
  • 236 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.